BioPharma Drug Discovery

Astellas Completes Acquisition of Propella Therapeutics

Through the acquisition of Propella, Astellas has acquired PRL-02 (abiraterone decanoate), a next-generation androgen biosynthesis inhibitor being develope...

 December 22, 2023 | News

Juniper Therapeutics Secures Exclusive SAR Registration Rights for COVID-19 Drug from Ping An-Shionogi HK in Singapore

Singapore-headquartered Juniper Therapeutix, a science-led healthcare company focused on commercializing novel therapies, announced its agreement with...

 December 22, 2023 | News

LTS Secures $4.3M Grant for Contraceptive Microneedle Array Patch Development

Poor access to contraceptives presents a significant burden for women living in LMICs. According to a 2022 study, one in 14 women worldwide who want to use...

 December 20, 2023 | News

NMPA Accepts Mabwell's 8MW0511 Injection New Drug Application

8MW0511, a Class 1 therapeutic biological product, is a new generation of long-acting G-CSF (modified cytokine with high activity) with independent intelle...

 December 20, 2023 | News

GC Biopharma's ALYGLO™ 10% Liquid FDA Approved for Adult Primary Immunodeficiency.

The ALYGLO pivotal phase 3 clinical study followed FDA guidance for the treatment of patients with PI. The clinical trial (NCT02783482) GC5107B was a prosp...

 December 18, 2023 | News

GeneQuantum and BioMap Collaborate on Next-Gen ADC Therapeutics

The partnership will combine GQ's proprietary enzymatic site-specific conjugation technology platforms (iLDC® and iGDC®), linker-payload platform, ...

 December 18, 2023 | News

Dr. Reddy’s First Indian Pharma Firm to Join Dow Jones Sustainability World Index

In a first for Indian pharma, Dr. Reddy’s is featured in the Dow Jones Sustainability World Index for 2023 Company retains its place in the ...

 December 15, 2023 | News

Fosun Pharma's Antimalarial Drug Trial Gets 500 Million Yen Boost from GHIT Fund for Global Accessibility Initiative

The Japan-based Global Health Innovative Technology Fund (GHIT Fund) announced that it will invest approximately US$3.3 million (approximate...

 December 15, 2023 | News

CStone's Sugemalimab Granted NMPA Approval for Esophageal Cancer

  Sugemalimab is the world's first anti-PD-L1 monoclonal antibody approved for use in combination with fluorouracil and platinum-based chemotherapy...

 December 11, 2023 | News

Merck Launches First Ever AI Solution to Integrate Drug Discovery and Synthesis

  Combines generative AI, machine learning and computer-aided drug-design to increase the success rate of new drugs and therapies Virtually screen...

 December 06, 2023 | News

Clarivate and VeriSIM Life Strengthen Collaboration for Efficient Drug Development

 Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, ...

 December 05, 2023 | News

FDA Prioritizes Review of PADCEV® Combo for Advanced Bladder Cancer

Results of pivotal confirmatory trial found the enfortumab vedotin plus pembrolizumab combination significantly extended overall survival and progres...

 December 04, 2023 | News

Alecensa by Roche Cuts Risk in Asian ALK-Positive Lung Cancer Patients by Over 60%.

 ALINA is the first and only Phase III study to show an improvement in disease-free survival in patients from Asia with early-stage resected ALK-posit...

 December 04, 2023 | News

AWS and Accenture Aid Merck in Cloud-Powered Drug Discovery and Clinical Trial Acceleration

At AWS re:Invent, Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), today announced it is working with Accenture (NYSE: ACN...

 November 30, 2023 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close